FSSNX
Price
$37.52
Change
-$0.20 (-0.53%)
Updated
Jul 2 closing price
Net Assets
34.92B
RYMCX
Price
$11.02
Change
-$0.36 (-3.16%)
Updated
Jul 2 closing price
Net Assets
412.68M
Interact to see
Advertisement

FSSNX vs RYMCX

FSSNX vs RYMCX Comparison Chart in %
View a ticker or compare two or three
VS
FSSNX vs. RYMCX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and RYMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 34.9B vs. RYMCX (413M). FSSNX pays higher dividends than RYMCX: FSSNX (1.02) vs RYMCX (0.00). FSSNX was incepted earlier than RYMCX: FSSNX (15 years) vs RYMCX (28 years). RYMCX (2.49) is less costly to investors than FSSNX (0.03). RYMCX is a more actively managed with annual turnover of: 38.00 vs. FSSNX (14.00). FSSNX has a lower initial minimum investment than RYMCX: FSSNX (0) vs RYMCX (2000). FSSNX (36.36) and RYMCX (34.88) have marching annual gain over last year. FSSNX return over 5 years is better than : 36.27 vs. RYMCX (-7.94).
FSSNXRYMCXFSSNX / RYMCX
Total Expense Ratio0.032.241%
Annual Report Gross Expense Ratio0.032.491%
Fund Existence15 years28 years-
Gain YTD21.47739.49454%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets34.9B413M8,450%
Annual Yield % from dividends1.020.00-
Returns for 1 year36.3634.88104%
Returns for 3 years65.1038.10171%
Returns for 5 years36.27-7.94-457%
Returns for 10 years161.8722.85708%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UPC6.320.76
+13.67%
Universe Pharmaceuticals Inc
NIQ9.880.26
+2.70%
NIQ Global Intelligence PLC
AKAM113.170.36
+0.32%
Akamai Technologies
CIVB28.46-0.54
-1.86%
Civista Bancshares
CPIX6.37-0.76
-10.66%
Cumberland Pharmaceuticals